Skip to main content
SpringerLink
Log in

Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Pharmacological spasm provocation tests such as acetylcholine (ACh) and ergonovine (ER) had been performed in the clinic. We retrospectively analyzed the incidence of provoked spasm, complications during testing and the cardiac events after these tests. From January 1991 and October 2018, we performed pharmacological spasm provocation tests in 2500 patients: 1810 ACh tests, 1232 ER tests, 542 both tests, and 310 ACh added after ER tests. ACh was injected in incremental doses of 20/50/100/200 μg into the LCA and 20/50/80 μg into the RCA. ER was administered as a total dose of 64 μg into the LCA and 40 μg into the RCA. When adding ACh after ER, the total dose was 50/80 μg into the RCA and 100/200 μg into the LCA. Positive spasm was defined as ≥ 90% stenosis and usual chest pain or ischemic ECG changes. Mean follow-up duration was 47.5 ± 29.9 months. Overall, provoked positive spasm was found in 1095 patients (43.8%). The incidence of positive provoked spasm during ACh testing was significantly higher than that during other tests (ACh: 48.7% vs. ER: 28.9%, Both: 24%, ACh added after ER: 33.5%, p < 0.001). Multiple spasms were remarkably more frequent during ACh testing compared with the other 3 types of testing (ACh: 28.2% vs. ER: 7.4%, Both: 4.1%, ACh added after ER: 13.2%, p < 0.001). No death or acute myocardial infarction was observed, while major complications during ACh testing were significantly more frequent than during ER testing. Readmission due to recurrent angina pectoris in spasm-positive patients was remarkably more frequent than in spasm-negative patients. The incidence of sudden cardiac death, ventricular fibrillation, and acute coronary syndrome were not different between the spasm-positive and spasm-negative groups during the follow-up periods. We could perform all spasm provocation tests without any irreversible complications. All sequential spasm provocation tests were useful for documenting coronary spasm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T (1986) Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74:955–963

    Article  CAS  Google Scholar 

  2. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, Matsuyama K (1988) Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 12:883–888

    Article  CAS  Google Scholar 

  3. Okumura K, Yasue H, Horio Y, Takaoka K, Matsuyama K, Kugiyama K, Fujii H, Morikami Y (1988) Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation 77:535–542

    Article  CAS  Google Scholar 

  4. Sato K, Kaikita K, Nakayama N, Horio E, Yoshimura H, Ono T, Ohba K, Tsujita K, Kojima S, Tayama S, Hokimoto S, Matsui K, Sugiyama S, Yamabe H, Ogawa H (2013) Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years. J Am Heart Assoc 2:e000227

    Article  Google Scholar 

  5. Ong P, Athabasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Udo Secctem (2012) High prevalence of a pathological reponse to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries: The ACOVA study. J Am Coll Cardiol 59:655–662

    Article  CAS  Google Scholar 

  6. Zaya M, Mehta PK, Merz NB (2014) Provocative testing for coronary reactivity and spasm. J Am Coll Cardiol 63:103–109

    Article  Google Scholar 

  7. Salerno JA, Previtali M, Tavazzi L, Chimienti M, De Servi S, Medici A, Specchia G, Bobba P (1982) Multivessel coronary spasm as a cause of ischemic syncope in angina at rest. Eur Heart J 3:339–345

    Article  CAS  Google Scholar 

  8. Nakamura M, Takeshita A, Nose Y (1987) Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 75:1110–1116

    Article  CAS  Google Scholar 

  9. Sueda S, Kohno H (2018) Impact of pharmacological spasm provocation test in patients with a history of syncope. Heart Vessels 33:126–133

    Article  Google Scholar 

  10. Meisel SR, Mazur A, Chetboun I, Epshtein M, Canetti M, Gallimidi J, Katz A, Strasberg B, Peled B (2002) Usefulness of implantable cardioverter-defibrillator in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. Am J Cardiol 89:1114–1116

    Article  Google Scholar 

  11. Sueda S, Fukuda H, Watanabe K, Ochi N, Kawada H, Hayashi Y, Uraoka T (2001) Clinical characteristics and possible mechanism of paroxysmal atrial fibrillation induced by intracoronary injection of acetylcholine. Am J Cardiol 88:570–573

    Article  CAS  Google Scholar 

  12. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, Uraoka T (2004) Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 55:403–411

    Article  Google Scholar 

  13. Sueda S, Saeki H, Otani T, Mineoi K, Kondou T, Yano K, Ochi T, Ochi N, Hayashi Y, Tsuruoka T, Kawada H, Matsuda S, Uraoka T (2000) Major complications during spasm provocation tests with an intracoronary injection of acetylcholine. Am J Cardiol 85:391–394

    Article  CAS  Google Scholar 

  14. Sueda S, Kohno H, Ochi T, Uraoka T (2015) Overview of the acetylcholine spasm provocation test. Clin Cardiol 38:430–438

    Article  Google Scholar 

  15. Sueda S, Kohno H, Ochi T, Uraoka T, Tsunemitus K (2017) Overview of the pharmacological spasm provocation test: comparisons between acetylcholine and ergonvoine. J Cardiol 69:57–65

    Article  Google Scholar 

  16. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, Uraoka T (2004) Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis 15:491–497

    Article  Google Scholar 

  17. Scanlon PJ, Faxon DP, Audet AM, Leon DL, Carabello B, Murray JA, Dehmer GJ, Nissen SE, Eagle KA, Pepine CJ, Legako RD, Watson RM, Ritchie JL, Gibbons RJ, Chettlin MD, Russell RO, Eagle KA, Ryan TJ, Gardner TJ, Smith SC Jr, Garson AG Jr (1999) ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol 33:1756–1824

    Article  CAS  Google Scholar 

  18. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A (2000) Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101:1102–1108

    Article  CAS  Google Scholar 

  19. Beltrame JF, Sasayama S, Maseri A (1999) Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33:1442–1452

    Article  CAS  Google Scholar 

  20. Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A (1987) Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 75:577–582

    Article  CAS  Google Scholar 

  21. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM (1982) Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 65:1299–1306

    Article  CAS  Google Scholar 

  22. Buxton A, Goldberg S, Hirshfeld JW, Wilson J, Mann T, Williams DO, Overlie P, Oliva P (1980) Refractory ergonovine induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol 46:329–334

    Article  CAS  Google Scholar 

  23. Harding MB, Leithe ME, Mark DB, Nelson CL, Harrison JK, Hermiller JB, Davidson CJ, Pryor DB, Bashore TM (1992) Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3447 patients without significant coronary artery disease or Prinzmetal’s variant angina. J Am Coll Cardiol 20:107–111

    Article  CAS  Google Scholar 

  24. Sueda S, Kohno H (2016) Overview of complications during pharmacological spasm provocation tests. J Cardiol 68:1–6

    Article  Google Scholar 

  25. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology [published correction appears in Eur Heart J 2014; 35: 2260–2261]. Eur Heart J 34:2949–3003

    Article  Google Scholar 

  26. Anderson JI, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff M, Peterson ED, Theroux P, Wenger NK, Wright S (2013) 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2013; 127: e863–e864]. Circulation 127:e663–e828

    Article  Google Scholar 

  27. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, Uraoka T (2003) Induction of coronary artery response by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine. Coron Artery Dis 14:451–457

    Article  Google Scholar 

  28. Sueda S, Miyoshi T, Sasaki Y, Skaue T, Habara H, Kohno H (2015) Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests. Coron Artery Dis 26:490–494

    Article  Google Scholar 

  29. JCS joint working group (2014) Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary spastic angina). Circ J 78:2779–2801

    Article  Google Scholar 

Download references

Funding

None

Author information

Authors and Affiliations

  1. Department of Cardiology, Ehime Niihama Prefectural Hospital, Hongou 3 choume 1-1, Niihama, Ehime, 792-0042, Japan

    Shozo Sueda

Authors
  1. Shozo Sueda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shozo Sueda.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sueda, S. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events. Heart Vessels 35, 1368–1377 (2020). https://doi.org/10.1007/s00380-020-01616-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-020-01616-x

Keywords

Search

Navigation